专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

AU2001279994B2 Trace elements 未知
公开(公告)号：AU2001279994B2
公开(公告)日：2004-09-02
申请号：AU2001279994
申请日：2001-08-17
申请人： VIRBAC AUSTRALIA PTY LTD
发明人： VOSLOO LAMBERTUS PETRUS , LAURIE ROBERT NAYLOR
IPC分类号： A23K20060101 , A23K1/175 , A23L20060101 , A61K31/28 , A61K33/00 , A61K33/04 , A61K45/06 , A61P3/02 , A61K033/04 , A23K001/175 , A61P003/02 , A61K033/34 , A61K033/32 , A61K033/30
摘要： A method of preparing a trace element solution includes the steps of providing at least one EDTA-complex, providing a sodium selenite solution, and combining the EDTA-complex(es) and the sodium selenite solution to form a trace element solution. A EDTA complex is prepared by using disodium EDTA or EDTA acid, selenium, and any other suitable mineral.

2. 发明申请

US20040213857A1 Multi-vitamin and mineral supplement for pregnant women 审中-公开
标题翻译：孕妇多元维生素和矿物质补充剂
公开(公告)号：US20040213857A1
公开(公告)日：2004-10-28
申请号：US10825477
申请日：2004-04-15
申请人： Boehringer Ingelheim International GmbH
发明人： Fabio Soldati , Lara Ambrosetti-Giudici
IPC分类号： A61K033/32 , A61K033/04 , A61K033/34
CPC分类号： A61K45/06 , A23L33/12 , A23L33/15 , A23L33/155 , A23L33/16 , A23V2002/00 , A61K33/24 , A61K33/34 , A61K2300/00 , A23V2250/1868 , A23V2250/7042 , A23V2250/7044 , A23V2250/211 , A23V2250/7052 , A23V2250/706 , A23V2250/70
摘要： The invention relates to pharmaceutical or dietary unit dosage form, which can be swallowed easily, consisting essentially of vitamins, minerals and trace elements recommended for consumption by pregnant women, lactating women or women of childbearing potential that are attempting to become pregnant, DHA and a pharmaceutically or dietetically suitable carrier.
摘要翻译：本发明涉及药物或膳食单位剂型，其易于吞咽，主要由维生素，矿物质和建议用于孕妇，哺乳期妇女或试图怀孕的生育潜力的妇女消费的微量元素组成，DHA和a 药学上或饮食上合适的载体。

3. 发明申请

US20040191331A1 Composition comprising particulate zinc materials having a defined crystallite size 审中-公开
标题翻译：包含具有确定的微晶尺寸的颗粒状锌材料的组合物
公开(公告)号：US20040191331A1
公开(公告)日：2004-09-30
申请号：US10742557
申请日：2003-12-19
申请人： The Procter & Gamble Company
发明人： James Robert Schwartz , Eric Scott Johnson , Bonnie Theresa King , Carl Hinz Margraf III , Gregory V. Tormos , David Thomas Warnke , Fred Christian Wireko
IPC分类号： A61K033/32
CPC分类号： A61Q17/005 , A61K8/27 , A61K8/4933 , A61K31/315 , A61K33/32 , A61K2800/413 , A61Q5/006 , A61Q5/12 , A61Q19/10 , B82Y5/00 , A61K2300/00
摘要： The present invention discloses a composition comprising a particulate zinc material wherein the particulate zinc material has a crystallite size less than 600 null. The present invention further comprises a shampoo composition comprising an effective amount of a surfactant, an effective amount of a particulate zinc material, an effective amount of a metal salt of pyrithione, and an effective amount of a suspending agent wherein the particulate zinc material has a crystallite size less than 600 null.
摘要翻译：本发明公开了一种包含颗粒状锌材料的组合物，其中颗粒状锌材料的微晶尺寸小于600。本发明还包括一种洗发剂组合物，其包含有效量的表面活性剂，有效量的颗粒状锌材料，有效量的吡啶硫酮金属盐和有效量的悬浮剂，其中颗粒状锌材料具有微晶尺寸小于600Å。

4. 发明申请

US20040170712A1 Medical effect of Jojoba Oil in the treatment of skin diseases 审中-公开
标题翻译：荷荷芭油治疗皮肤病的疗效
公开(公告)号：US20040170712A1
公开(公告)日：2004-09-02
申请号：US10792632
申请日：2004-03-04
申请人： Egyptian Natural Oil , South Egypt Drug Industries Co.
发明人： Nabil Sadek El Mogy
IPC分类号： A61K035/78 , A61K033/32
CPC分类号： A61Q19/00 , A61K8/922 , A61K36/185 , A61K2800/522 , A61Q5/004 , A61Q5/006 , A61Q7/00 , A61Q11/00 , A61Q17/02 , A61Q19/008 , B01D11/0288
摘要： In accordance with the present invention Jojoba Oil may be used in accordance with the treatment of and preventative measures associated with Gynecology of Obstetrics and general surgery, as well as in the treatment of eye diseases, inflammation of the internal, middle or external ear, rheumatic pain and arthritis, gingivostomatitis, toothache and dermal diseases. Jojoba oil is a natural product and is characterized by being non-irritant and non-allergic to skin and mucous membrane. This oil has lubricant, moisturizing and soothing properties, as well as having anti-bacterial, anti-inflammatory and anti-oxidant properties. It has a very high healing power and improves blood circulation, and also has high penetration into stratum corneum.
摘要翻译：根据本发明，可以根据与妇产科和普通外科手术相关的治疗和预防措施，以及治疗眼睛疾病，内耳，中耳或外耳炎，风湿病疼痛和关节炎，牙龈炎，牙痛和皮肤疾病。荷荷芭油是天然产物，其特征在于对皮肤和粘膜无刺激性和非过敏性。这种油具有润滑剂，保湿和舒缓性能，以及具有抗菌，抗炎和抗氧化的特性。它具有非常高的愈合力并改善血液循环，并且还具有高度渗入角质层。

5. 发明申请

US20040131700A1 Implantable medical devices using zinc 审中-公开
标题翻译：使用锌的植入式医疗器械
公开(公告)号：US20040131700A1
公开(公告)日：2004-07-08
申请号：US10692474
申请日：2003-10-22
申请人： Essentia Biosystems, Inc.
发明人： Pamela Cifra , Michael D. Dake , Christopher Elkins , Jacob M. Waugh
IPC分类号： A61F002/06 , A61K031/555 , A61K031/315 , A61K033/32
CPC分类号： A61K33/30 , A61K8/27 , A61K8/36 , A61K31/19 , A61K31/315 , A61K31/555 , A61K2800/10 , A61L29/106 , A61L29/14 , A61L31/088 , A61L31/14 , A61Q11/00 , A61Q19/00 , A61Q19/06 , A61Q19/08
摘要： Implantable medical devices using zinc, and methods therefore, provide one or more advantageous effects to a tissue. In one embodiment, at least one zinc-containing component is coupled with a stent via one or more zinc chelators to enhance resistance of the stent to plaque formation and in-stent restenosis. Elastin production may also be enhanced by devices coupled with zinc. Enhanced elastin production may be used, for example, to treat a blood vessel in location at or near an aneurysm. In some embodiments, both elastin production and plaque resistance are enhanced. For example, zinc may be applied via a gel or other carrier substance to a venous graft for enhancing elastin and resisting plaque formation. Implantable devices coupled with zinc may provide improved results of medical and surgical procedures involving implantable devices, thus reducing the need for repeat procedures.
摘要翻译：使用锌的植入式医疗装置及其方法因此为组织提供一个或多个有利效果。在一个实施方案中，至少一种含锌组分通过一种或多种锌螯合剂与支架结合，以增强支架对斑块形成和支架内再狭窄的抵抗力。弹性蛋白的生产也可以通过与锌偶联的装置来增强。可以使用增强的弹性蛋白生产，例如，在动脉瘤处或附近的位置处理血管。在一些实施方案中，增强了弹性蛋白的产生和抗斑块性。例如，可以通过凝胶或其它载体物质将锌施加到静脉移植物上，以增强弹性蛋白并抵抗斑块形成。与锌结合的可植入装置可提供涉及可植入装置的医疗和外科手术方面的改进结果，从而减少对重复手术的需要。

6. 发明申请

US20040131643A1 Immune response potentiation 审中-公开
标题翻译：免疫反应增强
公开(公告)号：US20040131643A1
公开(公告)日：2004-07-08
申请号：US10469920
申请日：2004-02-27
发明人： Harleen Grewal , Halvor Sommerfelt
IPC分类号： A61K039/106 , A61K033/32
CPC分类号： A61K33/30 , A61K39/107 , A61K39/39 , A61K45/06 , A61K2039/55505 , Y02A50/472 , A61K2300/00
摘要： The invention provides the use of a physiologically tolerable zinc compound for the manufacture of a medicament for use in a method of treatment of an animal to generate a mucosal immune response therein to an antigen, which method comprises administering to said animal a said physiologically tolerable zinc compound and a said antigen whereby to generate said response, preferably by bringing said zinc compound and said antigen into contact with a mucosal surface in said animal.
摘要翻译：本发明提供了生理上可耐受的锌化合物在制备用于治疗动物以在抗原中产生粘膜免疫应答的方法中的药物的用途，所述方法包括向所述动物施用所述生理上可耐受的锌化合物和所述抗原，从而通过使所述锌化合物和所述抗原与所述动物的粘膜表面接触来产生所述应答。

7. 发明申请

US20040109902A1 Dermatological formulations 审中-公开
标题翻译：皮肤科配方
公开(公告)号：US20040109902A1
公开(公告)日：2004-06-10
申请号：US10432848
申请日：2004-01-28
发明人： Emma Louise McDonagh , Rebecca Louise Kanis
IPC分类号： A61K031/315 , A61K033/32 , A61K031/7052
CPC分类号： A61K31/7056 , A61K9/0014 , A61K9/06 , A61K33/30 , A61K47/38 , A61K2300/00
摘要： Aqueous preparations of substantially equimolor amounts of a zinc salt and clindamycin phosphate form a polymer useful in the topical treatment of acne and rosacea, with very low systemic levels of clindamycin.
摘要翻译：基本上等量的锌盐和克林霉素的水性制剂形成可用于局部治疗痤疮和酒渣鼻的聚合物，其具有非常低的克林霉素的全身水平。

8. 发明申请

US20040101541A1 Electrolytic cream 审中-公开
标题翻译：电解奶油
公开(公告)号：US20040101541A1
公开(公告)日：2004-05-27
申请号：US10304168
申请日：2002-11-27
发明人： Michael Scully Heffernan , Jennifer Anne George
IPC分类号： A61K007/00 , A61K033/38 , A61K033/32 , A61K033/24
CPC分类号： A61K33/24 , A61K33/32 , A61K33/38 , A61K36/886 , A61K2300/00
摘要： In the past topical creams and lotions were mainly designed to be used to reduce pain and inflammation, and not necessarily to promote healing or regeneration. When existing remedies were designed to promote healing they were designed to do so by chemical mediation, e.g. by removing pain and/or blocking inflammatory produced substances produced in reaction to injury. The current invention is designed to operate entirely by a different mechanism of electrolytic induction. Using a composition of atomic metals suspended in a water based emulsion and suspension negative ion and polarity is induced in areas of the body where needed.
摘要翻译：在过去，局部乳膏和洗剂主要设计用于减轻疼痛和炎症，而不一定促进愈合或再生。当现有的治疗方法旨在促进愈合时，他们的设计是通过化学调解来实现的。通过消除疼痛和/或阻断在损伤反应中产生的炎症产生物质。本发明被设计成完全由不同的电解感应机理来操作。使用悬浮在水基乳液中的原子金属组合物和悬浮负离子和极性在需要的身体的区域中被诱导。

9. 发明申请

US20040091551A1 Topical composition and application system 审中-公开
标题翻译：专题组成和应用系统
公开(公告)号：US20040091551A1
公开(公告)日：2004-05-13
申请号：US10294500
申请日：2002-11-13
发明人： Al-Karim Damji
IPC分类号： A61K033/32
CPC分类号： A61K31/00 , A61K33/32 , A61K45/06 , A61K2300/00
摘要： A topical composition and application system for effectively and efficiently treating and/or preventing diaper dermatitis. The composition includes an amount of active medicinal ingredient, one or more non-medicinal ingredients used for enhancing the utility of the topical composition, and a carrier for application through either a spray-type applicator or impregnated upon a pre-moistened disposable towelette. The active ingredient is preferably zinc oxide ranging from 5 to 50% by weight, although any other active ingredient used for the prevention and/or treatment of diaper dermatitis may be used. The non-medicinal agent used may include any of the following: dimethicone, lanolin, mineral oil, petrolatum, antimicrobial agents, urea, calcium undecylenate, talc, starch, calcium carbonate, cod liver oil, Aloe, vitamin A, vitamin D, vitamin E, benzalkonium chloride, stearic acid, cetyl alcohol, skin soothing agents, emollients, moisteners, humectants, powders, pH stabilizers, chelating agents and emulsifiers.
摘要翻译：用于有效和有效地治疗和/或预防尿布性皮炎的局部组合物和应用系统。组合物包括一定量的活性药物成分，用于增强局部组合物的用途的一种或多种非药物成分，以及通过喷雾式施用器施用或浸渍在预先润湿的一次性毛巾上的载体。尽管可以使用用于预防和/或治疗尿布性皮炎的任何其它活性成分，但活性成分优选为5〜50重量％的氧化锌。所使用的非药物可以包括以下任何一种：聚二甲基硅氧烷，羊毛脂，矿物油，凡士林，抗菌剂，尿素，十一碳烯酸钙，滑石粉，淀粉，碳酸钙，鳕鱼肝油，芦荟，维生素A，维生素D，维生素 E，苯扎氯铵，硬脂酸，鲸蜡醇，皮肤舒缓剂，润肤剂，润湿剂，保湿剂，粉剂，pH稳定剂，螯合剂和乳化剂。

10. 发明申请

US20040052863A1 Nutritional supplement to treat macular degeneration 审中-公开
标题翻译：营养补充治疗黄斑变性
公开(公告)号：US20040052863A1
公开(公告)日：2004-03-18
申请号：US10641668
申请日：2003-08-15
发明人： Stephen Paul Bartels , Cara Larraine Baustian , George Edwin Bunce , Leon Ellenbogen , Frederick L. Ferris III , Jin Kinoshita , James Cecil Smith JR. , David A. Souerwine
IPC分类号： A61K031/355 , A61K033/34 , A61K033/32 , A61K031/375 , A61K031/015
CPC分类号： A61K33/34 , A23L5/44 , A23L33/105 , A23L33/15 , A23L33/155 , A23L33/16 , A23V2002/00 , A61K31/07 , A61K31/355 , A61K31/375 , A61K33/30 , A61K2300/00 , A23V2250/708 , A23V2250/712 , A23V2250/211 , A23V2250/1642 , A23V2250/1588 , A23V2250/2104 , A23V2250/2132 , A23V2250/702
摘要： A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.
摘要翻译：营养或膳食补充剂组合物，通过降低发生晚期或晚期年龄相关性黄斑变性的黄斑变性的风险，通过预防，稳定，逆转和/或治疗视力丧失来增强和促进视网膜健康退化。营养或膳食补充剂组合物同样可以降低与白内障发展相关的视力丧失的风险。营养或膳食补充剂组合物的基本成分是维生素C，维生素E，β-胡萝卜素，锌和铜。必需成分优选以适于口服摄取的片剂形式提供。优选地，组合物以每天两次服用一片或两片片剂的形式服用。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式